Dr Richard Clarkson
Projects as PI
- A conserved transcription pathway in the involuting mammary gland (01/03/2006 - 07/10/2009)
- ASTRA2 - Access to patient samples for translational research award (01/11/2019 - 30/10/2023)
- Building collaboration with Debiopharm, a major European biopharmaceutical company, for mutual knowledge exchange and asset growth (01/03/2022 - 30/09/2023)
- CB1: Discovery phase project (01/02/2022 - 01/04/2025)
- Cellesce Pilot PDX Project CSE01 (01/03/2021 - 31/10/2021)
Projects as Co-Investigator
- Discovery of Bdi3 inhibitors for the potential treatment of metastatic cancer (01/10/2013 - 30/09/2016)
- Enhancing the therapeutic efficacy of Poly ADP Ribose Polymerase (PARP) inhibitors in prostate cancer (01/08/2018 - 31/07/2021)
- Evaluation of CT26 and 4T1 tumour and metastases targeting of RAW 264.7 (labelled with [89Zr]oxinate-4 and 89zr-DFO-derritin) using PET (01/08/2017 - 31/07/2019)
- Exploring the concept of the cancer stem cell (01/10/2014 - 31/12/2019)
- Human gammadelta T cells for immunotherapy of breast cancer (01/10/2011 - 30/06/2015)